Reality check: should we use vancomycin for the prophylaxis of intravascular catheter-associated infections?
The use of intravascular catheters is associated with increased risk of bloodstream infections, principally caused by coagulase-negative staphylococci. This "Reality Check" session, held at the 4th Decennial International Conference on Nosocomial and Healthcare-Associated Infections, focused on the question of whether, and in what manner, vancomycin should be used for the prophylaxis of these infections
Grohskopf
L A
LA
Hospital Infections Program, National Center for Infectious Diseases, Centers for Disease Control and Prevention, United States Department of Health and Human Services, Atlanta, Georgia 30333, USA.
Maki
D G
DG
Sohn
A H
AH
Sinkowitz-Cochran
R L
RL
Jarvis
W R
WR
Goldmann
D A
DA
D002408:Catheters, Indwelling / Q000009:adverse effects*; D003428:Cross Infection / Q000517:prevention & control*; D006801:Humans; D013203:Staphylococcal Infections / Q000209:etiology / Q000517:prevention & control*; D014640:Vancomycin / Q000009:adverse effects / Q000627:therapeutic use*; D020713:Vancomycin Resistance
D014640:Vancomycin